miRNAs in precancerous lesions of the gastrointestinal tract

World Journal of Gastroenterology

Volumn 17, Issue 48, 2011, Pages 5231-5239

  Fassan, Matteo ^b   Croce, Carlo M ^c   Rugge, Massimo ^a,b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Atro phic gastritis; Barrett's esophagus; Dysplasia; Infammatory bowel disease; MiRNA

Indexed keywords

MESSENGER RNA; MICRORNA; PARAFFIN;

ARTICLE; BARRETT ESOPHAGUS; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM CANCER; ENTERITIS; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL CARCINOMA; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRECANCER; RELIABILITY; SECONDARY PREVENTION;

EID: 84455173386     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i48.5231     Document Type: Article

References (81)

1. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, Di Mario F. Gastritis: the histology report. Dig Liver Dis 2011; 43 Suppl 4: S373-S384
2. Fiocca R, Mastracci L, Milione M, Parente P, Savarino V. Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis 2011; 43 Suppl 4: S319-S330
3. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A. MicroRNA expression profling of human metastatic cancers identifes cancer gene targets. J Pathol 2009; 219: 214-221
4. Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A. Mi-croRNA expression profiling of male breast cancer. Breast Cancer Res 2009; 11: R58
5. Lehmann U. MicroRNA-profling in formalin-fxed paraffn-embedded specimens. Methods Mol Biol 2010; 667: 113-125
6. Visone R, Petrocca F, Croce CM. Micro-RNAs in gastrointestinal and liver disease. Gastroenterology 2008; 135: 1866-1869
7. O'Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF. Mi-croRNAs: key modulators of posttranscriptional gene expression. Gastroenterology 2009; 136: 17-25
8. Albulescu R, Neagu M, Albulescu L, Tanase C. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn 2011; 11: 101-120
9. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856
10. Croce CM. Causes and consequences of microRNA dysregu-lation in cancer. Nat Rev Genet 2009; 10: 704-714
11. Lee RC, Feinbaum RL, Ambros V. The C. elegans heteroch-ronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854
12. Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13: 497-502
13. Nuovo GJ. In situ detection of precursor and mature microR-NAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 2008; 44: 39-46
14. Nuovo GJ, Elton TS, Nana-Sinkam P, Volinia S, Croce CM, Schmittgen TD. A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 2009; 4: 107-115
15. Kan T, Meltzer SJ. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 2009; 9: 727-732
16. Belair C, Darfeuille F, Staedel C. Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 2009; 15: 806-812
17. Wang J, Wang Q, Liu H, Hu B, Zhou W, Cheng Y. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett 2010; 297: 137-143
18. Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010; 16: 531-537
19. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. Mi-croRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29: 5761-5771
20. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011; 32: 247-253
21. Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 2011; 104: 893-898
22. Cassaro M, Rugge M, Tieppo C, Giacomelli L, Velo D, Nitti D, Farinati F. Indefnite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol 2007; 60: 615-621
23. Zaninotto G, Minnei F, Guirroli E, Ceolin M, Battaglia G, Bel-lumat A, Betetto G, Bozzola L, Cassaro M, Cataudella G, Dal Bò N, Farinati F, Florea G, Furlanetto A, Galliani E, Germanà B, Guerini A, Macrì E, Marcon V, Mastropaolo G, Meggio A, Miori G, Morelli L, Murer B, Norberto L, Togni R, Valiante F, Rugge M. The Veneto Region's Barrett's Oesophagus Reg istry: aims, methods, preliminary results. Dig Liver Dis 2007; 39: 18-25
24. Rugge M, Meggio A, Cataudella G, Parente P, Salvagnini G, de Pretis G, Zaninotto G. Barrett's esophagus: still much to learn, but "Yes, we can!". Am J Gastroenterol 2008; 103: 2944-2946; author reply 2944-2946
25. Rugge M, Fassan M, Battaglia G, Parente P, Zaninotto G, Ancona E. Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia. Hum Pathol 2009; 40: 1206-1207; author reply 1206-1207
26. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105: 493-498
27. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Basso D, Plebani M, Graham DY. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathologi-cal follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-1111
28. Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Battaglia G, Rizzetto C, Parente P, Ancona E. Aurora kinase A in Barrett's carcinogenesis. Hum Pathol 2010; 41: 1380-1386
29. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. MicroRNA expression profles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-260; discussion 260
30. Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 2009; 15: 5744-5752
31. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 2010; 97: 853-861
32. Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge M. MicroRNA expression profling in human Barrett's carcinogenesis. Int J Cancer 2011; 129: 1661-1670
33. Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S, Rastogi A, Wani SB, Gupta N, Visvanathan M, Sharma P, Christenson LK. Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol 2011; 106: 1055-1063
34. Hino K, Tsuchiya K, Fukao T, Kiga K, Okamoto R, Kanai T, Watanabe M. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 2008; 14: 1433-1442
35. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009; 174: 1940-1948
36. Fassan M, Pizzi M, Battaglia G, Giacomelli L, Parente P, Bo-cus P, Ancona E, Rugge M. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol 2010; 63: 692-696
37. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarw-al R, Paun BC, Jin Z, Olaru AV, Selaru FM, Hamilton JP, Yang J, Abraham JM, Mori Y, Meltzer SJ. The miR-106b-25 polycistron, activated by genomic amplification, functions as an onco-gene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700
38. Dijckmeester WA, Wijnhoven BP, Watson DI, Leong MP, Michael MZ, Mayne GC, Bright T, Astill D, Hussey DJ. Mi-croRNA-143 and -205 expression in neosquamous esopha-geal epithelium following Argon plasma ablation of Barrett's esophagus. J Gastrointest Surg 2009; 13: 846-853
39. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26: 311-320
40. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X. Genetic variations in microRNA-related genes are novel susceptibil-ity loci for esophageal cancer risk. Cancer Prev Res (Phila) 2008; 1: 460-469
41. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
42. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659-672
43. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011; 128: 361-370
44. Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH. Identifcation of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced infammation. FEBS Lett 2010; 584: 1481-1486
45. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the infammatory response. J Infect Dis 2009; 200: 916-925
46. Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T, Churin Y, Gerhard M, Meyer TF. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One 2010; 5: e9500
47. Liu Z, Xiao B, Tang B, Li B, Li N, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Ding H, Zhao X, Guo H, Mao X, Zou Q. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced infammatory response in human gastric epithelial cells. Microbes Infect 2010; 12: 854-863
48. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010; 15: 524-531
49. Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichi-nose M, Sugiyama T, Ushijima T. DNA methylation of mi-croRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic feld defect. Int J Cancer 2009; 124: 2367-2374
50. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yo-shikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic feld defect. Carcinogenesis 2010; 31: 2066-2073
51. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H. A polymorphism of microRNA 27a genome region is associated with the development of gastric muco-sal atrophy in Japanese male subjects. Dig Dis Sci 2007; 52: 1691-1697
52. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting pro-hibitin. Cancer Lett 2009; 273: 233-242
53. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-1366
54. Zhu YM, Zhong ZX, Liu ZM. Relationship between let-7a and gastric mucosa cancerization and its signifcance. World J Gastroenterol 2010; 16: 3325-3329
55. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol 2007; 13: 2883-2888
56. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, Zhang WG, Nan KJ, Song TS, Huang C. MicroRNA profling of human gastric cancer. Mol Med Report 2009; 2: 963-970
57. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-1179
58. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-286
59. Morson BC. Precancerous lesions of the colon and rectum. Classification and controversial issues. JAMA 1962; 179: 316-321
60. East JE, Saunders BP, Jass JR. Sporadic and syndromic hy-perplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008; 37: 25-46, v
61. Lanza G, Messerini L, Gafà R, Risio M. Colorectal tumors: the histology report. Dig Liver Dis 2011; 43 Suppl 4: S344-S355
62. Xie J, Itzkowitz SH. Cancer in infammatory bowel disease. World J Gastroenterol 2008; 14: 378-389
63. Ahmadi A, Polyak S, Draganov PV. Colorectal cancer surveillance in infammatory bowel disease: the search continues. World J Gastroenterol 2009; 15: 61-66
64. Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 1925; 170: 220-228
65. Faber C, Kirchner T, Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch 2009; 454: 359-367
66. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 2010; 411: 1181-1186
67. Shah MS, Schwartz SL, Zhao C, Davidson LA, Zhou B, Lupton JR, Ivanov I, Chapkin RS. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiol Genomics 2011; 43: 640-654
68. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010; 70: 6609-6618
69. Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 2010; 73: 185-191
70. Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Puc-ciarelli S, Rugge M. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 2011; 458: 413-419
71. Schmitz KJ, Hey S, Schinwald A, Wohlschlaeger J, Baba HA, Worm K, Schmid KW. Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Virchows Arch 2009; 455: 49-54
72. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, Landi S. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008; 29: 579-584
73. Landia D, Morenob V, Guinob E, Vodickac P, Pardinic B, Naccaratic A, Canziand F, Baralea R, Gemignania F, Landia S. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: A review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res 2010; 717: 109-115
74. Dalal SR, Kwon JH. The Role of MicroRNA in Infammatory Bowel Disease. Gastroenterol Hepatol (N Y) 2010; 6: 714-722
75. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Melt-zer SJ, Brant SR, Kwon JH. Identifcation of microRNAs associated with ileal and colonic Crohn's disease. Infamm Bowel Dis 2010; 16: 1729-1738
76. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Hirata I, Arisawa T. Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis. J Clin Immunol 2011; 31:69-73
77. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hébuterne X, Harel-Bellan A, Mograbi B, Darfeuille-Michaud A, Hof-man P. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 2011; 43: 242-245
78. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635.e24
79. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R, Bouhnik Y, Laburthe M, Groyer A, Ogier-Denis E. Identifca-tion of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with infam-matory bowel disease. PLoS One 2010; 5: 1-12
80. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, Cheng Y, Jin Z, Yang J, Agarwal R, Abraham JM, Dasso-poulos T, Harris M, Bayless TM, Kwon J, Harpaz N, Livak F, Meltzer SJ. Dynamic changes in the expression of MicroR-NA-31 during infammatory bowel disease-associated neo-plastic transformation. Infamm Bowel Dis 2011; 17: 221-231
81. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, Brant SR, Kwon JH. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Infamm Bowel Dis 2011; 17: 241-250